First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Renowned machine learning researcher and New York Times best-selling author,
Each quarter, I round up and highlight some of my favorite articles written by Mitchell experts and let you know where we have been published outsi
October 2019 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Executive Vice-President, ADESA Analytical
In 2019, we have seen a variety of workers’ compensation tre
With the end of 2019 rapidly approaching, it is only natural to start thinking about the year ahead.
This article is authored by guest blogger, Deborah Robinson Stewart, National Manager of Medicare Set-Asides, Genex Services. In its simpl